Phase 2 Hepatitis B trials recruiting now

All Hepatitis B trials, every phase

Other phases for Hepatitis B

Phase 2 Hepatitis B trials

• A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
  NCT07069569 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 14 locations
• A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
  NCT06425341 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
  NCT05769816 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
  NCT05771402 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
  NCT07200193 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 4 locations
• A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
  NCT06947499 · Phase: Phase 2, Phase 3 · Ages: 6 Weeks to 8 Weeks · Sex: All (male and female) · 1 location
• A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
  NCT06263959 · Phase: Phase 2 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
  NCT05417932 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations
• A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
  NCT07635186 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 34 locations
• A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
  NCT07137910 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
• A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
  NCT06650852 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 14 locations
• Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
  NCT07413549 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection
  NCT07519330 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
  NCT06295328 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
  NCT06154278 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Liver Cancer Disparities in American Indian and Alaska Native Persons
  NCT05304234 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
  NCT05832229 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 13 locations
• Methylene Blue Treatment of Chronic Hepatitis B Virus Infection
  NCT06887036 · Phase: Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · 1 location
• Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
  NCT07370207 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations
• Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
  NCT07654283 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations
• Study of AHB-171 in Chronic Hepatitis B Participants
  NCT07630727 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations
• Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
  NCT07709520 · Phase: Phase 2 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• Study of LW231 in Participants With Chronic Hepatitis B
  NCT07179575 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
  NCT06513286 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations
• VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
  NCT06092333 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
  NCT06216470 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.